Allergan, Amgen Submit BLA for Avastin Biosim

ABP 215 is the most advanced of the four oncology biosimilar medicines on which Amgen and Allergan are collaborating
Source: PharmaManufacturing.com - Category: Pharmaceuticals Source Type: news